1. Home
  2. STVN vs AB Comparison

STVN vs AB Comparison

Compare STVN & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$16.80

Market Cap

3.7B

ML Signal

HOLD

Logo AllianceBernstein Holding L.P.

AB

AllianceBernstein Holding L.P.

HOLD

Current Price

$40.07

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STVN
AB
Founded
1949
1987
Country
Italy
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Investment Managers
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.3B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
STVN
AB
Price
$16.80
$40.07
Analyst Decision
Buy
Hold
Analyst Count
3
5
Target Price
$25.67
$40.40
AVG Volume (30 Days)
597.9K
211.7K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
0.39%
8.59%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.67
N/A
Revenue Next Year
$9.99
$6.45
P/E Ratio
$27.15
$13.85
Revenue Growth
N/A
N/A
52 Week Low
$12.89
$35.59
52 Week High
$28.00
$44.11

Technical Indicators

Market Signals
Indicator
STVN
AB
Relative Strength Index (RSI) 69.76 63.24
Support Level $13.58 $38.70
Resistance Level $17.19 $40.78
Average True Range (ATR) 0.74 0.65
MACD 0.23 0.13
Stochastic Oscillator 88.03 90.56

Price Performance

Historical Comparison
STVN
AB

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

About AB AllianceBernstein Holding L.P.

AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (41%), and private (18%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of January 2026, the company had $875.0 billion in managed assets, composed primarily of fixed-income (36% of AUM) and equity (41%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.

Share on Social Networks: